These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10803727

  • 1. Assessment of similarity between dissolution profiles.
    Ma MC, Wang BB, Liu JP, Tsong Y.
    J Biopharm Stat; 2000 May; 10(2):229-49. PubMed ID: 10803727
    [Abstract] [Full Text] [Related]

  • 2. Statistical comparison between dissolution profiles of drug products.
    Chow SC, Ki FY.
    J Biopharm Stat; 1997 May; 7(2):241-58. PubMed ID: 9136067
    [Abstract] [Full Text] [Related]

  • 3. A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
    Maggio RM, Castellano PM, Kaufman TS.
    Eur J Pharm Sci; 2008 May 10; 34(1):66-77. PubMed ID: 18394869
    [Abstract] [Full Text] [Related]

  • 4. Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
    Novick S, Shen Y, Yang H, Peterson J, LeBlond D, Altan S.
    J Biopharm Stat; 2015 May 10; 25(2):351-71. PubMed ID: 25357203
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Permutation Test (PT) and Tolerated Difference Test (TDT): two new, robust and powerful nonparametric tests for statistical comparison of dissolution profiles.
    Gómez-Mantilla JD, Casabó VG, Schaefer UF, Lehr CM.
    Int J Pharm; 2013 Jan 30; 441(1-2):458-67. PubMed ID: 23194886
    [Abstract] [Full Text] [Related]

  • 8. Modelling drug dissolution from controlled release products using genetic programming.
    Do DQ, Rowe RC, York P.
    Int J Pharm; 2008 Mar 03; 351(1-2):194-200. PubMed ID: 18053658
    [Abstract] [Full Text] [Related]

  • 9. An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.
    Laitinen R, Lahtinen J, Silfsten P, Vartiainen E, Jarho P, Ketolainen J.
    J Pharm Biomed Anal; 2010 Jun 05; 52(2):181-9. PubMed ID: 20116958
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.
    Vertzoni M, Dressman J, Butler J, Hempenstall J, Reppas C.
    Eur J Pharm Biopharm; 2005 Aug 05; 60(3):413-7. PubMed ID: 15893920
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple-time-point dissolution specifications for a sampling acceptance plan.
    Chen JJ, Tsong Y.
    J Biopharm Stat; 1997 May 05; 7(2):259-70. PubMed ID: 9136068
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of drug dissolution profiles: a proposal based on tolerance limits.
    Zhai S, Mathew T, Huang Y.
    Stat Med; 2016 Dec 20; 35(29):5464-5476. PubMed ID: 27501158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.